Literature DB >> 2983931

Receptors for T-cell growth factor: structure, function and expression on normal and neoplastic cells.

W C Greene, R J Robb.   

Abstract

Mesh:

Substances:

Year:  1985        PMID: 2983931     DOI: 10.1007/978-1-4684-4838-2_1

Source DB:  PubMed          Journal:  Contemp Top Mol Immunol        ISSN: 0090-8800


× No keyword cloud information.
  7 in total

1.  Depressed 3H-thymidine incorporation by measles infected mononuclear cells can be corrected by treatment with isoprinosine or 5-fluoro-2-deoxyuridine.

Authors:  R Lomnitzer; A R Rabson
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

Review 2.  Soluble inhibitors of T lymphocyte proliferation: tools for dissecting pathways of T cell activation.

Authors:  J C Reed; P C Nowell
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

Review 3.  [Pterins: pigments, cofactors and signal connections in cell interactions].

Authors:  I Ziegler
Journal:  Naturwissenschaften       Date:  1987-12

4.  Sequential expression of protooncogenes during lectin-stimulated mitogenesis of normal human lymphocytes.

Authors:  J C Reed; J D Alpers; P C Nowell; R G Hoover
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

5.  Standardization of sensitive human immunodeficiency virus coculture procedures and establishment of a multicenter quality assurance program for the AIDS Clinical Trials Group. The NIH/NIAID/DAIDS/ACTG Virology Laboratories.

Authors:  F B Hollinger; J W Bremer; L E Myers; J W Gold; L McQuay
Journal:  J Clin Microbiol       Date:  1992-07       Impact factor: 5.948

6.  Low and high affinity cellular receptors for interleukin 2. Implications for the level of Tac antigen.

Authors:  R J Robb; W C Greene; C M Rusk
Journal:  J Exp Med       Date:  1984-10-01       Impact factor: 14.307

7.  Stable expression of cDNA encoding the human interleukin 2 receptor in eukaryotic cells.

Authors:  W C Greene; R J Robb; P B Svetlik; C M Rusk; J M Depper; W J Leonard
Journal:  J Exp Med       Date:  1985-07-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.